Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01022307 · ClinicalTrials.gov registry record
Quantitative Automated Lesion Detection of Traumatic Brain Injury
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 212
- Enrollment target
NCT01022307: Completed study, sponsored by VA Office of Research and Development.
NCT01022307 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 212 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01022307 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 212 participants
- Enrollment target
Study Summary
The investigators propose to develop quantitative automated lesion detection (QALD) procedures to identify brain damage following traumatic brain injury more accurately than is possible with a normal magnetic resonance imaging (MRI) scans. These procedures require about 1 hour of imaging in an MRI scanner. Subjects will also undergo about 2 hours of cognitive tests. The investigators will compare the results of the cognitive tests with those from MRI scanning to determine what brain regions are responsible for superior performance and for performance decrements.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2009-05 |
| Est. Completion | 2014-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01022307
The ClinicalTrials.gov registry entry for NCT01022307 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01022307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01022307 about?
NCT01022307 is a clinical study titled "Quantitative Automated Lesion Detection of Traumatic Brain Injury". The investigators propose to develop quantitative automated lesion detection (QALD) procedures to identify brain damage following traumatic brain injury more accurately than is possible with a normal magnetic resonance imaging (MRI) scans. These procedures require about 1 hour of imaging in an MRI s...
What is the current status of trial NCT01022307?
This trial is currently completed. The enrollment target is 212 participants. The study started on 2009-05. Estimated completion is 2014-10.
Who is sponsoring clinical trial NCT01022307?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.